这是描述信息

董事长介绍/The Chairman

  • 分类:企业介绍
  • 发布时间:2019-12-29 00:00:00
  • 访问量:0
概要:
概要:
详情

 

曹德良博士 / Dr. Deliang Cao


湖南莱拓福生物科技有限公司董事长、法人、首席科学家,前美国南伊利诺伊大学医学院医学微生物学、免疫学和细胞生物学系、Simmons肿瘤研究所终身教授(Tenured),博士生导师。国家特聘专家,湖南省“百人计划”专家,“芙蓉学者奖励计划”讲座教授。

曹博士是AKR1B10基因发现者,AKR1B10原发性肝癌诊断试剂盒《醛酮还原酶1B10测定试剂盒》(埃克欣® AKR)发明者;发表SCI收录科研学术论文110余篇,其中AKR1B10 相关SCI 论文 32 篇,AKR1B10 单篇最高被引355次,是全球AKR1B10研究的引领者。获得美国发明专利3项,中国发明专利4项,申报在审发明专利4项。

曹博士于2021年9月全职回国工作,兼任南华大学和湖南中医药大学特聘教授;肝癌早诊早治湖南省工程研究中心主任、首席科学家。

 

 

 

 

Chairman, legal person and chief scientist of Hunan Light of Life Biotechnology Co., Ltd. a former tenured professor and doctoral supervisor in Department of Medical Microbiology, Immunology and Cell Biology & Simmons Cancer Institute at Southern Illinois University School of Medicine. He was awarded the "Hundred Talents Program" Scholars of Hunan Province in 2013 and the "Furong Scholars Award Program" Chair Professor of Hunan Province in 2020.

Dr. Cao is the discoverer of the AKR1B10 gene and the inventor of the AKR1B10 primary liver cancer diagnostic product "Aldo-keto Reductase 1B10 Assay Kit"; he has published 102 scientific research papers incited in SCI, including 32 SCI papers in AKR1B10 with a single AKR1B10 paper Cited up to 355 times. Dr. Cao is the global leader in AKR1B10 research. He has obtained 3 American invention patents and 4 Chinese invention patents with 4 patents under peer review.

Professor Cao has resigned all titles in USA and been back to China full-time in September 2021, and he also serves as a Distinguished Professor at the University of South China and Hunan University of Traditional Chinese Medicine. Dr. Cao is committed to marketing of self-developed patents for the medical health of humans.

扫二维码用手机看